Literature DB >> 17935601

Old drugs--new uses.

J K Aronson.   

Abstract

Mesh：

Year:  2007        PMID： 17935601      PMCID： PMC2203255          DOI： 10.1111/j.1365-2125.2007.03058.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN： 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  22 in total

1.  The price of innovation: new estimates of drug development costs.

Authors:  Joseph A DiMasi; Ronald W Hansen; Henry G Grabowski
Journal:  J Health Econ       Date:  2003-03       Impact factor: 3.883

Review 2.  Beta irradiation: new uses for an old treatment: a review.

Authors:  J F Kirwan; P H Constable; I E Murdoch; P T Khaw
Journal:  Eye (Lond)       Date:  2003-03       Impact factor: 3.775

3.  [Pharmacodynamic properties of 3-chloro-10-(3-dimethylaminopropyl)-phenothiazine hydrochloride (R.P. 4560); experimental study of a new substance used in potentialized anesthesia and in artificial hibernation].

Authors:  S COURVOISIER; J FOURNEL; R DUCROT; M KOLSKY; P KOETSCHET
Journal:  Arch Int Pharmacodyn Ther       Date:  1953-01

4.  QTc-interval abnormalities and psychotropic drug therapy in psychiatric patients.

Authors:  J G Reilly; S A Ayis; I N Ferrier; S J Jones; S H Thomas
Journal:  Lancet       Date:  2000-03-25       Impact factor: 79.321

5.  The "liquid cosh" libel.

Authors: 
Journal:  Br Med J (Clin Res Ed)       Date:  1983-01-08

6.  Psychotropic drugs and long QT syndromes: case reports.

Authors:  M Y Flugelman; A Tal; S Pollack; A Hefez; E B Weisstub; M S Gotsman; B S Lewis
Journal:  J Clin Psychiatry       Date:  1985-07       Impact factor: 4.384

7.  Miltefosine as a topical treatment for cutaneous metastases in breast carcinoma.

Authors:  S Clive; J Gardiner; R C Leonard
Journal:  Cancer Chemother Pharmacol       Date:  1999       Impact factor: 3.333

Review 8.  Tretinoin. A review of its pharmacodynamic and pharmacokinetic properties and use in the management of acute promyelocytic leukaemia.

Authors:  J C Gillis; K L Goa
Journal:  Drugs       Date:  1995-11       Impact factor: 9.546

9.  Trial of oral miltefosine for visceral leishmaniasis.

Authors:  S Sundar; F Rosenkaimer; M K Makharia; A K Goyal; A K Mandal; A Voss; P Hilgard; H W Murray
Journal:  Lancet       Date:  1998-12-05       Impact factor: 79.321

10.  Thioridazine-induced torsade de pointes. Successful therapy with isoproterenol.

Authors:  A J Kemper; R Dunlap; D A Pietro
Journal:  JAMA       Date:  1983-06-03       Impact factor: 56.272
View more
  29 in total

1.  Drug discovery in a multidimensional world: systems, patterns, and networks.

Authors:  Joel T Dudley; Eric Schadt; Marina Sirota; Atul J Butte; Euan Ashley
Journal:  J Cardiovasc Transl Res       Date:  2010-07-31       Impact factor: 4.132

Review 2.  Exploiting drug-disease relationships for computational drug repositioning.

Authors:  Joel T Dudley; Tarangini Deshpande; Atul J Butte
Journal:  Brief Bioinform       Date:  2011-06-20       Impact factor: 11.622

3.  Repurposing an old drug for a new use: glybenclamide exerts antiplatelet activity by interacting with the thromboxane A(2) receptor.

Authors:  Harold J Ting; Wallace J Murray; Fadi T Khasawneh
Journal:  Acta Pharmacol Sin       Date:  2010-02       Impact factor: 6.150

Review 4.  The curious stories of drugs with two lives: a new paradigm in drug development.

Authors:  Ross MacPherson
Journal:  J R Soc Med       Date:  2015-03-31       Impact factor: 5.344

Review 5.  The neuroimmune transcriptome and alcohol dependence: potential for targeted therapies.

Authors:  Anna Warden; Emma Erickson; Gizelle Robinson; R Adron Harris; R Dayne Mayfield
Journal:  Pharmacogenomics       Date:  2016-12-05       Impact factor: 2.533

Review 6.  Contributions from emerging transcriptomics technologies and computational strategies for drug discovery.

Authors:  Onat Kadioglu; Thomas Efferth
Journal:  Invest New Drugs       Date:  2014-03-16       Impact factor: 3.850

Review 7.  Cell-Based Assay Design for High-Content Screening of Drug Candidates.

Authors:  Gregory Nierode; Paul S Kwon; Jonathan S Dordick; Seok-Joon Kwon
Journal:  J Microbiol Biotechnol       Date:  2016-02       Impact factor: 2.351

8.  Δ²,³-ivermectin ethyl secoester, a conjugated ivermectin derivative with leishmanicidal activity but without inhibitory effect on mammalian P-type ATPases.

Authors:  François Noël; Paulo Henrique Cotrim Pimenta; Anderson Rouge Dos Santos; Erick Carlos Loureiro Tomaz; Luis Eduardo Menezes Quintas; Carlos Roland Kaiser; Claudia Lucia Martins Silva; Jean-Pierre Férézou
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2010-11-19       Impact factor: 3.000

9.  Discovery and preclinical validation of drug indications using compendia of public gene expression data.

Authors:  Marina Sirota; Joel T Dudley; Jeewon Kim; Annie P Chiang; Alex A Morgan; Alejandro Sweet-Cordero; Julien Sage; Atul J Butte
Journal:  Sci Transl Med       Date:  2011-08-17       Impact factor: 17.956

10.  Carglumic acid promotes apoptosis and suppresses cancer cell proliferation in vitro and in vivo.

Authors:  Chun-Te Chen; Yi-Chun Chen; Hirohito Yamaguchi; Mien-Chie Hung
Journal:  Am J Cancer Res       Date:  2015-11-15       Impact factor: 6.166
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.